Genomic Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Genomic Vision's historical fundamentals, such as revenue growth or operating cash flow patterns.
Genomic
Genomic Vision Socit has current Daily Balance Of Power of (0.06). Balance of Power indicator (or BOP) measures the strength of Genomic Vision Socit market sensitivity to bulls and bears. It estimates the ability of Genomic Vision buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Genomic Vision Balance of Power indicator one can determine a trend of the price direction.
On December 01 2024 Genomic Vision Socit was traded for 706.78 at the closing time. The highest daily price throughout the period was 712.73 and the lowest price was 702.88 . There was no trading activity during the period 0.0. Lack of trading volume on 12/01/2024 did not cause price change. The overall trading delta to current closing price is 0.11% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
For every potential investor in Genomic, whether a beginner or expert, Genomic Vision's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Genomic Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Genomic. Basic forecasting techniques help filter out the noise by identifying Genomic Vision's price trends.
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genomic Vision stock to make a market-neutral strategy. Peer analysis of Genomic Vision could also be used in its relative valuation, which is a method of valuing Genomic Vision by comparing valuation metrics with similar companies.
Genomic Vision Socit Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Genomic Vision's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Genomic Vision's current price.
Market strength indicators help investors to evaluate how Genomic Vision stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Genomic Vision shares will generate the highest return on investment. By undertsting and applying Genomic Vision stock market strength indicators, traders can identify Genomic Vision Socit entry and exit signals to maximize returns.
The analysis of Genomic Vision's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Genomic Vision's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting genomic stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Genomic Vision financial ratios help investors to determine whether Genomic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genomic with respect to the benefits of owning Genomic Vision security.